Literature DB >> 16850290

[PresbyLASIK: treatment approaches with the excimer laser].

K A Becker1, A Jaksche, F G Holz.   

Abstract

Presbyopia represents the most common refractive error. There is currently no surgical treatment for presbyopia, which is effective, reliable, and safe. Excimer laser surgery has become a routine procedure for the correction of myopia, hyperopia, and astigmatism for years. Various treatment strategies for presbyopia have been brought forward using the excimer lasers. Besides monovision, creation of a multifocal cornea represents an attractive option. This procedure is also called "PresbyLASIK." Different ablation profiles to form a multifocal cornea are reviewed here and first clinical results are summarized."PresbyLASIK" is a new, interesting treatment strategy, with a huge potential for the future. At the present it should be used in controlled studies only because of some unsolved questions.

Entities:  

Mesh:

Year:  2006        PMID: 16850290     DOI: 10.1007/s00347-006-1391-y

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  35 in total

1.  The effect of monovision contact lens wear on driving performance.

Authors:  Joanne M Wood; Kristan Wick; Vicki Shuley; Brendon Pearce; Dean Evans
Journal:  Clin Exp Optom       Date:  1998 May-Jun       Impact factor: 2.742

Review 2.  Restoration of accommodation.

Authors:  Adrian Glasser
Journal:  Curr Opin Ophthalmol       Date:  2006-02       Impact factor: 3.761

Review 3.  Success of monovision in presbyopes: review of the literature and potential applications to refractive surgery.

Authors:  S Jain; I Arora; D T Azar
Journal:  Surv Ophthalmol       Date:  1996 May-Jun       Impact factor: 6.048

4.  Corneal asphericity and visual function after radial keratotomy.

Authors:  J F Fleming
Journal:  Cornea       Date:  1993-05       Impact factor: 2.651

5.  Excimer laser surgery of the cornea.

Authors:  S L Trokel; R Srinivasan; B Braren
Journal:  Am J Ophthalmol       Date:  1983-12       Impact factor: 5.258

6.  Biometric, optical and physical changes in the isolated human crystalline lens with age in relation to presbyopia.

Authors:  A Glasser; M C Campbell
Journal:  Vision Res       Date:  1999-06       Impact factor: 1.886

7.  A corneal flap technique for laser in situ keratomileusis. Human studies.

Authors:  I G Pallikaris; M E Papatzanaki; D S Siganos; M K Tsilimbaris
Journal:  Arch Ophthalmol       Date:  1991-12

8.  Changes in the shape of the anterior and posterior corneal surfaces caused by mydriasis and miosis: detailed analysis.

Authors:  Kahori Saitoh; Kenji Yoshida; Yasuhiro Hamatsu; Yutaka Tazawa
Journal:  J Cataract Refract Surg       Date:  2004-05       Impact factor: 3.351

9.  Evaluation of a satisfied bilateral scleral expansion band patient.

Authors:  Lisa A Ostrin; Sanjeev Kasthurirangan; Adrian Glasser
Journal:  J Cataract Refract Surg       Date:  2004-07       Impact factor: 3.351

10.  Centered vs. inferior off-center ablation to correct hyperopia and presbyopia.

Authors:  J M Bauerberg
Journal:  J Refract Surg       Date:  1999 Jan-Feb       Impact factor: 3.573

View more
  4 in total

1.  A new method of cornea modulation with excimer laser for simultaneous correction of presbyopia and ametropia.

Authors:  Detlef Uthoff; Markus Pölzl; Daniel Hepper; Detlef Holland
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-22       Impact factor: 3.117

Review 2.  [Accommodation and presbyopia : part 2: surgical procedures for the correction of presbyopia].

Authors:  M Baumeister; T Kohnen
Journal:  Ophthalmologe       Date:  2008-11       Impact factor: 1.059

3.  [Functional results after bilateral intrastromal femtosecond laser correction of presbyopia].

Authors:  R Khoramnia; M P Holzer; A Fitting; G U Auffarth; T M Rabsilber
Journal:  Ophthalmologe       Date:  2013-12       Impact factor: 1.059

Review 4.  Presbyopic correction on the cornea.

Authors:  Samuel Arba Mosquera; Jorge L Alió
Journal:  Eye Vis (Lond)       Date:  2014-11-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.